Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers

Inclusion Criteria: * Healthy women aged from 18 to 40, inclusive. * Verified diagnosis "healthy": absence gastrointestinal, hepatic, renal, cardiovascular, endocrine, central nervous system, ear, nose, throat (ENT) and gynecological disorders (performed standard clinical, laboratory and instrumental assessments did not reveal any disorders). * Body mass index (BMI) within range from 18.5 to 30 kg/m\^2. * Subject consent not to intake alcohol during the entire study period; negative alcohol breath test at screening and before start of Investigational Product administration. * Negative pregnancy test result at screening and before start of Investigational Product administration. * Consent to use adequate methods of contraception throughout the study. * Normal regular menstrual cycle of 28 +/- 7 days duration for at least 6 months before study enrollment. * Women with stable sexual partner. Exclusion Criteria: * Chronic cardiovascular, respiratory, neuroendocrine, genitourinary systems disorders, as well as gastrointestinal, hepatic, renal, blood, and ENT disorders (including acute and chronic rhinitis, sinusitis, and others). * Gynecological disorders (polycystic ovary syndrome, mommas, endometriosis, inflammatory diseases and others). * Positive cervical cytology Papanicolaou (PAP) test in medical anamnesis within 12 months before screening. * Lab abnormalities (blood hematology and biochemistry and urinalysis) at screening. * Electrocardiogram (ECG) abnormalities at scree…